Securities
Issues & Trends
PROTEINA CO., LTD. Partners with U.S.-Based Twist BioSciences to Validate AI-Driven New Drug Development
AI-driven new drug development company #PROTEINA CO., LTD. announced on the 27th that it has partnered with Twist Bioscience, a company listed on the U.S. Nasdaq, to collaborate on the development of …
Issues & Trends
Finemedix Co., Ltd. Participates in Korea-U.S. Joint R&D… Developing an Endoscope-Based Pancreatic Cancer Treatment Device
#Finemedix Co., Ltd., a gastrointestinal endoscopy solutions company, announced on the 27th that it has been selected as a joint research institution for the Ministry of Health and Welfare’s “2026 Res…
Issues & Trends
NGeneBio Co., Ltd. Signs MOU with Incheon Sejong Hospital to Develop Customized Testing for GLP-1 Obesity Treatment
AI precision medicine company NGeneBio Co., Ltd.(354200)announced on the 27th that it has signed a Memorandum of Understanding (MOU) with Incheon Sejong Hospital to jointly develop genetic and blood t…
Issues & Trends
VIVOZON PHARMACEUTICAL Signs Contract to Supply Finished Anaprazu Products to Hainan Special Medical Zone in China
VIVOZON PHARMACEUTICAL(082800)is accelerating its entry into the Chinese market with its non-narcotic analgesic “Anapraz.” VIVOZON PHARMACEUTICAL announced on the 27th that it has signed a contract wi…
Issues & Trends
LINCSOLUTION CO., LTD. Sees Mass Production Expansion Take Shape with First Foundry Order—Shinhan
On the 26th, Shinhan Investment Securities stated that LINCSOLUTION CO., LTD. has confirmed the range of items capable of mass production via 3D printing by securing its first foundry order from a maj…
Stock Reports
"HanmiPharm’s New Obesity Drug Prevents Muscle Loss… Target Price Raised to 650,000 Won" – Shinhan
On the 27th, Shinhan Investment Securities projected that the value of HanmiPharm’s entire obesity treatment pipeline would be reevaluated following the company’s technology export of a new obesity dr…
Stock Reports
SK BIOPHARMACEUTICALS Secures Next-Generation Epilepsy Drug… Target Price Raised to 160,000 Won—Hana
Hana Securities assessed that SK BIOPHARMACEUTICALS(326030)has secured a new drug candidate for epilepsy, thereby establishing a growth engine following Excofry. The firm maintained its “Buy (BUY)” ra…
Stock Reports
SK Innovation to Merge with SKIET … "Policies to Protect Existing Shareholders Are Needed"
Hana Securities stated on the 27th that while it assesses SK Innovation(096770)has proactively mitigated the risk of default stemming from the #SKIET merger by absorption, it is necessary to establish…
Stock Reports
HyundaiMotor Target Price Lowered… Why, Despite Growth in Its Robotics Business?
On the 27th, SamsungSecurities lowered its target price for HyundaiMotor(005380)from 650,000 won to 600,000 won, a 7.7% reduction. This decision stems from the assessment that while HyundaiMotor Group…
Global News
Major Floods in Nepal… 19 Dead, 384 Missing, Including a South Korean
Massive flooding in north-central Nepal has left 19 people dead and hundreds missing. Eight of the missing foreigners are reported to be South Koreans.
Local residents look at homes submerged in mu…